CLOV
Get informed when a big investor buys or sells
+ FollowOvervalued by 170.4% based on the discounted cash flow analysis.
| Market cap | $2.44 Billion |
|---|---|
| Enterprise Value | $2.24 Billion |
| Dividend Yield | $- (-) |
| Earnings per Share | $-0.17 |
| Beta | 2.46 |
| Outstanding Shares | 524,186,885 |
| P/E Ratio | -113.58 |
|---|---|
| PEG | 31.14 |
| Price to Sales | 1.15 |
| Price to Book Ratio | - |
| Enterprise Value to Revenue | 0.91 |
| Enterprise Value to EBIT | -122.24 |
| Enterprise Value to Net Income | -123 |
| Total Debt to Enterprise | 0 |
| Debt to Equity | 0 |
No data
Market sentiment based on institutional option activity.
| Put/Call Ratio | 0.0000▼ 32.86% |
|---|---|
| Total Calls | -▼ 100.00% |
| Total Puts | -▼ 100.00% |
Holdings and activity of institutional investors.
| Ownership % | 0.12%▼ 28.86% |
|---|---|
| Total Invested | $2.69M▼ 99.66% |
| Investors Holding | 16▼ 226.00% |
No data
Clover Health is a healthcare technology company with a deeply rooted mission of improving every life. Clover uses its proprietary technology platform to collect, structure, and analyze health and behavioral data to improve medical outco...